Screening for liver cancer in people with cirrhosis
People with HCV cirrhosis are at risk for liver cancer. Regular screening can detect early-stage liver cancer.
Usually, screening consists of a liver scan by ultrasound or computed tomography (CT scan, a medical scan that produces images on a computer from sections inside the body), and a blood test measuring alphafetoprotein (AFP, a protein made in foetal liver tissue) levels. Screening is recommended every six months.